Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke

Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke

BackgroundStroke is a leading cause of long‐term disability worldwide. However, current therapies that promote functional recovery from stroke are limited to physical rehabilitation. No pharmacological therapy is available. Thus, understanding the role of histone deacetylase 2 (HDAC2) in the pathoph...

Full description

Bibliographic Details
Main Authors:	Ying Tang, Yu‐Hui Lin, Huan‐Yu Ni, Jian Dong, Hong‐Jin Yuan, Yu Zhang, Hai‐Ying Liang, Meng‐Cheng Yao, Qi‐Gang Zhou, Hai‐Yin Wu, Lei Chang, Chun‐Xia Luo, Dong‐Ya Zhu
Format:	Article
Language:	English
Published:	Wiley 2017-10-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	epigenetics functional recovery histone deacetylase 2 histone deacetylase inhibitor stroke
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.117.007236

Similar Items

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
by: Svetlana Demyanenko, et al.
Published: (2021-10-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
by: Fengyi Guo, et al.
Published: (2022-11-01)

Role of Histone Deacetylases in T-Cell Development and Function
by: Monika Pieniawska, et al.
Published: (2022-07-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024-02-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
by: Bernardina Scafuri, et al.
Published: (2020-12-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Characterization of Histone Deacetylase Mechanisms in Cancer Development
by: Rihan Hai, et al.
Published: (2021-07-01)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
by: Long Xu, et al.
Published: (2023-10-01)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
by: Amandine Badie, et al.
Published: (2022-11-01)

Subcellular localization of class I histone deacetylases in the developing Xenopus tectum
by: Xia eGuo, et al.
Published: (2016-01-01)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Dose Effects of Histone Deacetylase Inhibitor Tacedinaline (CI-994) on Antipsychotic Haloperidol-Induced Motor and Memory Side Effects in Aged Mice
by: Bryan McClarty, et al.
Published: (2021-10-01)

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
by: Giorgio Milazzo, et al.
Published: (2020-05-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

The Role of HDACs as Leukemia Therapy Targets using HDI
by: Ahmad Ahmadzadeh, et al.
Published: (2016-02-01)

Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
by: Nikolaos Garmpis, et al.
Published: (2022-10-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Histone deacetylases and their roles in mineralized tissue regeneration
by: Nam Cong-Nhat Huynh, et al.
Published: (2017-12-01)

Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
by: Jie Ran, et al.
Published: (2019-03-01)

Histone acetylation modifiers in the pathogenesis of Alzheimer’s disease
by: Xi eLu, et al.
Published: (2015-06-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
by: Donglu Wu, et al.
Published: (2020-11-01)

Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
by: Richard S. Laschanzky, et al.
Published: (2019-09-01)

Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents
by: Subhasish Tapadar, et al.
Published: (2020-10-01)

The histone deacetylase NlHDAC1 regulates both female and male fertility in the brown planthopper, Nilaparvata lugens
by: Jin-Li Zhang, et al.
Published: (2018-12-01)

In silico profiling of histone deacetylase inhibitory activity of compounds isolated from Cajanus cajan
by: Kayode Adewole, et al.
Published: (2022-01-01)

Antidepressant effect of the novel histone deacetylase-5 inhibitor T2943 in a chronic restraint stress mouse model
by: Juan Du, et al.
Published: (2024-02-01)

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
by: Surabhi Shukla, et al.
Published: (2020-04-01)

Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
by: Fabian B. Kraft, et al.
Published: (2023-02-01)

Gestation and breastfeeding in schistosomotic mice differentially alters the expression of histone deacetylases (HDACs) in adult offspring
by: Gabriela Calixto Ribeiro de Holanda, et al.

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)

Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates
by: Abdelhakim Bouyahya, et al.
Published: (2022-04-01)

Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
by: Kostas Palamaris, et al.
Published: (2023-02-01)

Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma
by: Maša Zrimšek, et al.
Published: (2022-08-01)

The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
by: Peedicayil J
Published: (2020-03-01)